+91-9660032889
+91-9660032889
support@mysiponline.com
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular - Payout of IDCW
- Equity
- Pharma & Healthcare
- Very High
-
₹20.44
(-1.3%)
Current NAV 08-05-2025
-
3.44%
Returns
-
Min. SIP ₹100
Min. Investment ₹1000
Fund Suitability Test
Returns (NAV as on 08-May-2025)
Track investment returns to meet financial goals.
| This Fund | Category Avg. | Benchmark | |
|---|---|---|---|
| 1W | -2.99% | -0.82% | 2.37% |
| 1M | 2.3% | 6.72% | 0% |
| 3M | -3.17% | -4.87% | -3.71% |
| 6M | -6.67% | -6.61% | 0% |
| 1Y | 3.44% | 16.53% | 0% |
| 2Y | 21.8% | 32.32% | 0% |
| 3Y | 11.99% | 21.68% | 0% |
| 5Y | 10.87% | 22.27% | 0% |
| ALL | 13.04% | 19.08% | 0% |
Check out what are trailling and rolling returns of this fund ?
View Detail Return Analysis1 Lac Users Opted for this Service
Free KYC Check
To know your eligibility for Mutual Fund Investment
Risk Analysis
| Standard Dev | Sharpe | Beta | Alpha | |
|---|---|---|---|---|
| Fund | 16.06% | 0.7% | 0.98% | -2.11% |
| Category | 15.76% | 0.86% | 0.86% | 0.86% |
Riskometer
Comparison Of Aditya Birla Sun Life Pharma and Healthcare Fund-Regular - Payout of IDCW
Compare your fund with the top category schemes.
UTI Nifty 50 Index Fund - Regular Plan - Growth Option
3Y Returns14.84% (p.a.)
DSP Nifty 50 Equal Weight Index Fund - Regular Plan - Growth
3Y Returns17.18% (p.a.)
ICICI Prudential Long Term Bond Fund - Growth
3Y Returns9.03% (p.a.)
Nippon India Nivesh Lakshya Fund- Growth Option
3Y Returns10.12% (p.a.)
UTI Short Duration Fund - Regular Plan - Growth Option
3Y Returns7.29% (p.a.)
UTI Short Duration Fund - Discontinued Regular Option -Growth Sub Option
3Y Returns6.99% (p.a.)
ITI Mid Cap Fund Regular - Growth
3Y Returns23.06% (p.a.)
Kotak Emerging Equity Scheme - Growth
3Y Returns19.79% (p.a.)
SIP Returns Calculator
A simple tool to calculate your SIP returns.
- Invested Amount
- Estimated Returns
- Future Value
Start small, dream big: Begin your journey to long-term wealth with SIPs starting at just ₹1000!
Start SIPPortfolio Summary (as on 31-Jan-2025)
An insight into your portfolio composition.
Equity94.26% Others5.74%
Equity Market Cap
Top 5 Sectors of Equity
Healthcare 93%
Basic Materials 1%
Top 5 Companies of Equity
Sun Pharmaceuticals Industries Ltd 15%
Cipla Ltd 9%
Torrent Pharmaceuticals Ltd 9%
Apollo Hospitals Enterprise Ltd 6%
Lupin Ltd 5%
Others Market Cap
Top 5 Sectors of Others
6%
Top 5 Companies of Others
Clearing Corporation Of India Limited 6%
Net Receivables / (Payables) -0%
Check out the favourite sectors and companies of this fund
Detail Portfolio AnalysisAlternative Fund Category Peer View
Check out the other Mutual Funds in this category
More Funds From Mutual Fund
Take test again
Chat with usFrequently Asked Questions
What is the current NAV of Aditya Birla Sun Life Pharma and Healthcare Fund-Regular - Payout of IDCW?
Net asset value is the per unit price of the mutual fund. The NAV of funds changes every day. The latest NAV of Aditya Birla Sun Life Pharma and Healthcare Fund-Regular - Payout of IDCW as of 08-05-2025 is 20.44.
What is the benchmark of Aditya Birla Sun Life Pharma and Healthcare Fund-Regular - Payout of IDCW?
performance is primarily benchmarked against the NIFTY 500 TRI with NIFTY 50 TRI serving as an addition.
Is Aditya Birla Sun Life Pharma and Healthcare Fund-Regular - Payout of IDCW a safe fund to invest?
Every fund has different types of risk which are mentioned in the risko-meter. The investors are advised to understand their risk tolerance and decide which type of fund they can invest in.
What are the top 5 holdings of Aditya Birla Sun Life Pharma and Healthcare Fund-Regular - Payout of IDCW?
The fund's top 5 sectors holdings are Healthcare, Basic Materials,
How can I redeem my investments in Aditya Birla Sun Life Pharma and Healthcare Fund-Regular - Payout of IDCW?
Redeeming your investments in Aditya Birla Sun Life Pharma and Healthcare Fund-Regular - Payout of IDCW is super easy.
• If you have invested this fund via MySIPonline, just log into the app, go to the investment section, and place your redemption request.
• If you have invested this fund from elsewhere, go to the fund house website and place your redemption request from there.
Who manages this fund, and what is their expertise?
Dhaval Shah, Dhaval Joshi, with an extensive experience of 15 years while managing equity & related investments. He is focused on picking quality companies and holds them for a long duration to generate good compounding returns in their funds.
What is the expense ratio of Aditya Birla Sun Life Pharma and Healthcare Fund-Regular - Payout of IDCW?
The expense ratio of a mutual fund means the charges that you pay to the mutual fund company for managing your investments in the fund. This fund has an expense ratio of 1.37%.
What is the AUM or size of Aditya Birla Sun Life Pharma and Healthcare Fund-Regular - Payout of IDCW?
AUM or asset under management is the total value of the assets held by a mutual fund scheme. A fund with a high AUM means a lot of money has been invested in it. The AUM of Aditya Birla Sun Life Pharma and Healthcare Fund-Regular - Payout of IDCW is Rs 815.09 Crs. Crs.
Should I invest in Aditya Birla Sun Life Pharma and Healthcare Fund-Regular - Payout of IDCW?
This fund has a consistency rating of which indicates that the fund has generated average returns. However, whatever returns that the fund delivers, it does so with exceptional consistency. You can consider this fund if the predictability of returns is what you are looking for.
How to start online SIP in Aditya Birla Sun Life Pharma and Healthcare Fund-Regular - Payout of IDCWs?
MySIPonline is a dedicated platform to start online SIP or mutual funds in any scheme of mutual funds. Firstly, the investor needs to complete KYC details, choose the best fund, add it to the cart, and make the payment through UPI, net banking, or debit card available on our site.
Is there any brokerage/advisory fees on Mutual Fund SIP transactions?
At MySIPonline, we do not charge any fees related to brokerage & advisory part. That makes us more accessible and cost-effective for a broader range of investors.
